Dr. Bazbek Davletov is a master mind of molecular engineering. His innovative work spanning three decades, vision, and commitment to finding cures for chronic pain are foundational to Neuresta. Dr. Davletov received a M.Sc. in biochemistry from Moscow State University and Ph.D. in molecular biology from the University of Texas Southwestern Medical Center at Dallas. While in Dallas, he studied the mechanisms of synaptic neurotransmitter release in the laboratory of Dr. Thomas C. Südhof, a renowned neuroscientist who was awarded the 2013 Nobel Prize in Physiology or Medicine. Dr. Davletov has been directing independent research programs focused on biology and therapeutic applications of neurotoxins since 1995. He was a Welcome Trust Fellow at the Imperial College London and, subsequently, a leader of the Medical Research Council program in Cambridge. In 2012, he became the Chair of Biomedical Science at the University of Sheffield. Dr. Davletov spearheaded productive international collaborations with academic scientists and large pharmaceutical companies. He published over 100 manuscripts in prestigious biomedical journals and delivered lectures across North America, Europe, and Asia.